---
title: 'Epstein-Barr virus latency patterns in polymorphic lymphoproliferative disorders
  and lymphomas in immunodeficiency settings: Diagnostic implications'
date: '2024-03-06'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38447253/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20240307170601&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: Epstein-Barr virus (EBV) is responsible for many B cell lymphoproliferative
  disorders (LPD) spanning subclinical infection to immunodeficiency-related neoplasms.
  EBV establishes a latent infection in the host B cell as defined histologically
  by the expression of EBV latent membrane proteins and nuclear antigens. Herein,
  we characterize the latency patterns of immunodeficiency-related neoplasms including
  post-transplant lymphoproliferative disorders (PTLD) and therapy-related LPD ...
disable_comments: true
---
Epstein-Barr virus (EBV) is responsible for many B cell lymphoproliferative disorders (LPD) spanning subclinical infection to immunodeficiency-related neoplasms. EBV establishes a latent infection in the host B cell as defined histologically by the expression of EBV latent membrane proteins and nuclear antigens. Herein, we characterize the latency patterns of immunodeficiency-related neoplasms including post-transplant lymphoproliferative disorders (PTLD) and therapy-related LPD ...